Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 5351-5400 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05283109
ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM
PHASE1Active, not recruiting
24 participants
Started: Aug 30, 2023 · Completed: Feb 29, 2028
1 condition2 sponsors1 location
NCT06007183
Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination
PHASE3Active, not recruiting
800 participants
Started: Aug 30, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor24 locations
NCT06389812
Dual-task Exercise in People With Cognitive Impairment
NAActive, not recruiting
30 participants
Started: Aug 30, 2023 · Completed: Sep 30, 2024
3 conditions1 sponsor1 location
NCT06096896
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
N/AActive, not recruiting
334 participants
Started: Aug 30, 2023 · Completed: Sep 30, 2030
1 condition1 sponsor1 location
NCT05693129
Pediatric Patients Aged 1 to 6 Years With APDS
PHASE3Active, not recruiting
16 participants
Started: Aug 30, 2023 · Completed: Feb 28, 2026
1 condition5 sponsors9 locations
NCT06074406
Low-Field Bedside Brain Magnetic Resonance Imaging in Pediatric Extracorporeal Membrane Oxygenation
NAActive, not recruiting
20 participants
Started: Aug 30, 2023 · Completed: Aug 30, 2026
3 conditions1 sponsor1 location
NCT06333964
A Study to Evaluate the Efficacy and Safety of AST-001 in ASD Children
PHASE3Active, not recruiting
169 participants
Started: Aug 29, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor11 locations
NCT05949281
Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
PHASE2Active, not recruiting
100 participants
Started: Aug 29, 2023 · Completed: Jun 15, 2026
3 conditions3 sponsors1 location
NCT05975619
A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System
NAActive, not recruiting
40 participants
Started: Aug 29, 2023 · Completed: Apr 30, 2026
4 conditions1 sponsor1 location
NCT05033379
Healthcare Worker Resilience as Measured by Physiologic Feedback
NAActive, not recruiting
400 participants
Started: Aug 29, 2023 · Completed: Jun 30, 2024
1 condition2 sponsors1 location
NCT05903339
Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV
PHASE1Active, not recruiting
36 participants
Started: Aug 29, 2023 · Completed: Dec 21, 2025
1 condition1 sponsor6 locations
NCT05041647
Cannabinoids As a Treatment for Insomnia in Major Depression
PHASE2Active, not recruiting
60 participants
Started: Aug 28, 2023 · Completed: Feb 28, 2025
5 conditions2 sponsors1 location
NCT05857761
GAIN Symptoms: Post-traumatic Headache
NAActive, not recruiting
62 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2027
3 conditions3 sponsors1 location
NCT06238609
Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome
NAActive, not recruiting
25 participants
Started: Aug 28, 2023 · Completed: Aug 28, 2025
3 conditions2 sponsors1 location
NCT05985356
Neuromodulation for Comorbid Hoarding Disorder and Depression
NAActive, not recruiting
12 participants
Started: Aug 28, 2023 · Completed: Apr 30, 2025
3 conditions1 sponsor1 location
NCT06181838
Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy With and Without Acne Lesions Extraction
NAActive, not recruiting
40 participants
Started: Aug 28, 2023 · Completed: Jan 3, 2024
2 conditions1 sponsor1 location
NCT06126224
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
PHASE3Active, not recruiting
400 participants
Started: Aug 28, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor119 locations
NCT05975268
A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis
PHASE3Active, not recruiting
747 participants
Started: Aug 28, 2023 · Completed: Oct 29, 2025
1 condition1 sponsor63 locations
NCT06390059
EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma
PHASE2Active, not recruiting
84 participants
Started: Aug 28, 2023 · Completed: Nov 27, 2025
1 condition1 sponsor15 locations
NCT05990452
Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
261 participants
Started: Aug 28, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05797233
Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
PHASE1Active, not recruiting
58 participants
Started: Aug 28, 2023 · Completed: Dec 30, 2029
3 conditions1 sponsor1 location
NCT05975554
The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.
NAActive, not recruiting
30 participants
Started: Aug 26, 2023 · Completed: Sep 1, 2025
3 conditions1 sponsor1 location
NCT06024876
A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia
EARLY_PHASE1Active, not recruiting
5 participants
Started: Aug 26, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT06039267
Brain Health & the Microbiome
N/AActive, not recruiting
90 participants
Started: Aug 25, 2023 · Completed: Aug 24, 2025
3 conditions1 sponsor1 location
NCT05954910
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
N/AActive, not recruiting
1,000 participants
Started: Aug 25, 2023 · Completed: May 31, 2027
1 condition1 sponsor29 locations
NCT05992935
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
PHASE1/PHASE2Active, not recruiting
1,285 participants
Started: Aug 25, 2023 · Completed: Nov 20, 2026
1 condition1 sponsor14 locations
NCT06250374
Assessment of the Cerebral Perfusion During the Period of Deep Hypothermia at 18°C in Patient Undergoing Pulmonary Endarterectomy Surgery.
NAActive, not recruiting
45 participants
Started: Aug 24, 2023 · Completed: May 24, 2025
4 conditions1 sponsor1 location
NCT05712356
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
PHASE2Active, not recruiting
67 participants
Started: Aug 24, 2023 · Completed: Mar 31, 2030
8 conditions1 sponsor19 locations
NCT06012136
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Suspension Injection of Investigational Capsid Inhibitors Compared to Placebo in Healthy Adults
PHASE1Active, not recruiting
85 participants
Started: Aug 24, 2023 · Completed: Jun 9, 2026
1 condition1 sponsor2 locations
NCT05962385
State Dependence of Prefrontal Transcranial Magnetic Stimulation
PHASE4Active, not recruiting
35 participants
Started: Aug 24, 2023 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT06423261
Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects
PHASE1Active, not recruiting
100 participants
Started: Aug 24, 2023 · Completed: Jul 29, 2026
1 condition1 sponsor1 location
NCT06014229
Cryoablation of Benign Thyroid Nodules: a Pilot Study
NAActive, not recruiting
10 participants
Started: Aug 24, 2023 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT05842057
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy
PHASE2Active, not recruiting
118 participants
Started: Aug 24, 2023 · Completed: Aug 31, 2028
2 conditions2 sponsors1 location
NCT05764252
A Prospective Diagnostic Belief Updating Study to verIfy the Utility of BioEP in First Seizure Clinics.
N/AActive, not recruiting
88 participants
Started: Aug 23, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05594225
Tele-Rehabilitation to Improve Mild Traumatic Brain Injury Recovery and Reduce Subsequent Injury Risk
PHASE1Active, not recruiting
88 participants
Started: Aug 23, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05903547
Skin Glue Cesarean Study
NAActive, not recruiting
200 participants
Started: Aug 23, 2023 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT05609669
Continuous And Data-drivEN CarE (CADENCE) Pilot
NAActive, not recruiting
10 participants
Started: Aug 23, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT06259695
Development and Usability of an Adjustable Prosthesis for Aquatic Therapy
NAActive, not recruiting
3 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05862324
TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)
PHASE1/PHASE2Active, not recruiting
113 participants
Started: Aug 23, 2023 · Completed: Aug 1, 2027
1 condition1 sponsor9 locations
NCT05723523
A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment
NAActive, not recruiting
3,001 participants
Started: Aug 23, 2023 · Completed: Sep 30, 2025
2 conditions3 sponsors2 locations
NCT05720832
Feasibility of Technology-Based SSIP in Prostate Cancer Patients
NAActive, not recruiting
27 participants
Started: Aug 23, 2023 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location
NCT05935514
Improving Glycemic Control Using a Virtual Weight Control Program and Continuous Glucose Monitoring
NAActive, not recruiting
152 participants
Started: Aug 22, 2023 · Completed: Nov 15, 2025
3 conditions2 sponsors3 locations
NCT06183294
Evaluation of a Novel Non-Invasive Automated Fractional Flow Reserve Software System in Patients With Coronary Artery Disease
N/AActive, not recruiting
100 participants
Started: Aug 22, 2023 · Completed: Aug 21, 2025
1 condition2 sponsors1 location
NCT05970289
Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients
PHASE2Active, not recruiting
86 participants
Started: Aug 22, 2023 · Completed: Feb 28, 2026
1 condition2 sponsors29 locations
NCT03767478
Neuromuscular Electrical Stimulation For The Treatment of Diabetic Neuropathy
NAActive, not recruiting
65 participants
Started: Aug 22, 2023 · Completed: Jun 30, 2025
4 conditions2 sponsors1 location
NCT05947474
ORB-011 In Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
55 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT06677489
CKD-Heart: Heart Failure Prediction in Asian CKD Patients
N/AActive, not recruiting
1,000 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06293222
Patient and Public Involvement and Engagement in Research With Children and Young People With Sickle Cell Disorder and Their Families
N/AActive, not recruiting
20 participants
Started: Aug 21, 2023 · Completed: Apr 30, 2024
1 condition2 sponsors1 location
NCT05991310
Evaluating the Safety and Efficacy of Telemedicine Neurology Assessments on a Mobile Stroke Unit
NAActive, not recruiting
270 participants
Started: Aug 21, 2023 · Completed: May 31, 2025
2 conditions1 sponsor1 location
NCT05872854
Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light
PHASE2Active, not recruiting
20 participants
Started: Aug 21, 2023 · Completed: Dec 15, 2025
2 conditions2 sponsors1 location